Prima Facie Case
Subscribe to Prima Facie Case's Posts

Flattery will get you nowhere: Copying and industry praise defeat obviousness challenge

The US Court of Appeals for the Federal Circuit affirmed the Patent Trial & Appeal Board’s decisions finding that Google failed to establish obviousness of certain challenged claims. The Court found that secondary considerations of nonobviousness, including evidence of copying and industry praise, outweighed Google’s evidence of obviousness. Google LLC v. DDC Technology, LLC, Case Nos. 25-1315; -1316; -1330 (Fed. Cir. Nov. 5, 2026) (Reyna, Hughes, Stark, JJ.)

DDC owns three patents directed to virtual reality viewers for use with smartphones. Google petitioned the Board for inter partes review (IPR) of those patents, asserting that the challenged claims were obvious over a combination of two prior art references. Although the Board found that the combined references taught every limitation of certain claims and that a skilled artisan would have been motivated to combine those references with a reasonable expectation of success, the Board nevertheless concluded that evidence of copying and industry praise outweighed Google’s evidence of obviousness. Google appealed.

The Federal Circuit affirmed the Board’s determination of nonobviousness and clarified the role of secondary considerations in the obviousness inquiry. As for the copying factor, the Federal Circuit explained that copying requires replication of a specific product, as opposed to merely showing that competing products fall within the same patent claims. Copying may be established through internal documents, direct evidence of replication, or evidence of access to and substantial similarity to the patented product. The Court rejected Google’s argument that the Board had improperly compared the products to the challenged claims rather than each other, noting that the Board directly compared Google’s viewer with DDC’s viewer and inventor Patrick Buckley’s prototype and found substantial similarity.

Next, Google attacked DDC’s industry praise evidence consisting of emails from Google engineers responding to videos of Buckley’s prototype with comments such as “[t]hat button is genius.” Google contended that these statements were biased compliments arising from a prospective business relationship rather than genuine industry praise. The Federal Circuit disagreed, explaining that the engineers were commenting on a third party’s prototype, and that the Board had accounted for the engineers’ potential lack of impartiality by discounting one response as mere politeness and recognizing that the business relationship reduced the probative value of the other two responses.

Google further argued that its “strong” prima facie case of obviousness outweighed DDC’s “marginal” evidence of secondary considerations. The Federal Circuit disagreed, citing two major reasons. First, the Federal Circuit clarified that the four-factor framework established by the US Supreme Court in Graham v. John Deere requires analysis of all four factors governing obviousness, including secondary considerations of nonobviousness. This analysis must be conducted regardless of the strength of the prior art showing, although weak objective evidence may not overcome a substantially stronger showing of obviousness.

Second, the Federal Circuit distinguished the burden-shifting imposed during patent prosecution from IPR proceedings. During prosecution, an examiner’s prima facie showing of unpatentability shifts the burden of coming forward with evidence to the applicant. The Federal Circuit explained that this burden-shifting framework does not [...]

Continue Reading




read more

Prima Facie Obviousness Established Where Claimed pH Range Overlaps with Prior Art Range for Similar Compounds

The US Court of Appeals for the Federal Circuit reversed a district court’s summary judgment that found a patent was not obvious because the claimed pH range would not have been obvious-to-try despite overlapping ranges between the claimed pH range and the pH range for similar prior art compounds. Valeant Pharms. Intl. v. Mylan Pharms. Inc., Case No. 18-2097 (Fed. Cir. Apr. 8, 2020) (Lourie, J.).

(more…)




read more

STAY CONNECTED

TOPICS

ARCHIVES